|4/AMay 14, 4:35 PM ET

Evans Elizabeth E. 4/A

4/A · VACCINEX, INC. · Filed May 14, 2024

Insider Transaction Report

Form 4/AAmended
Period: 2024-03-21
Evans Elizabeth E.
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-21+1,3411,341 total
    Exercise: $8.21Exp: 2034-03-21Common Stock (1,341 underlying)
Footnotes (2)
  • [F1]Due to an administrative error, the original Form 4 mistakenly listed the transaction date as March 20, 2024. The transaction actually occurred on March 21, 2024. Accordingly, the exercise price of the stock option is $8.21 per share, as opposed to the exercise price of $8.32 that was listed in the original Form 4.
  • [F2]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 21, 2024 grant date.

Documents

1 file
  • 4
    form4a.xml

    AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES